13F filerCIK 1536411 ↗
Duquesne Family Office
You are looking at Q1 2018. See the latest, Q3 2026 →
Reported value
$1.81B
−8.8% on the quarter before
Positions
22
11 new, 19 sold out
Top 10
86.8%
of the value
Est. gain
+$148.3M
on stocks held all quarter
Est. return
+13.4%
on those stocks since Q4 2017
Positions as of Mar 31, 2018, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2017. Striped tiles are options.
Largest buys
Since Q4 2017, sized at quarter-end prices.
- Intel~$128.3MNew, 0.0% → 7.1% of the portfolio+2,462,600 shares
- Alibaba~$120.7MNew, 0.0% → 6.7% of the portfolio+657,400 shares
- Micron~$114.1MNew, 0.0% → 6.3% of the portfolio+2,187,500 shares
- Netflix~$56.0MNew, 0.0% → 3.1% of the portfolio+189,700 shares
- Jd Com Inc~$27.7MAdded, 2.3% → 4.0% of the portfolio+684,800 shares
- Adobe~$26.5MNew, 0.0% → 1.5% of the portfolio+122,500 shares
- Tal Ed Group~$25.3MNew, 0.0% → 1.4% of the portfolio+682,000 shares
- Qualcomm~$22.8MNew, 0.0% → 1.3% of the portfolio+411,000 shares
- Vipshop Hldgs Ltd~$9.5MNew, 0.0% → 0.5% of the portfolio+572,800 shares
- Sterling Bancorp Del~$9.1MNew, 0.0% → 0.5% of the portfolio+401,600 shares
Largest sells
Since Q4 2017, sized at quarter-end prices.
- Meta~$191.0MSold out, 9.6% → 0.0% of the portfolio−1,082,200 shares
- Microsoft~$72.8MCut, 13.9% → 12.3% of the portfolio−797,600 shares
- Nektar Therapeutics~$68.2MCut, 5.5% → 7.0% of the portfolio−641,700 shares
- Eog Res Inc~$56.6MSold out, 2.9% → 0.0% of the portfolio−524,700 shares
- Wells Fargo Co New~$51.6MSold out, 2.6% → 0.0% of the portfolio−850,000 shares
- Bank Amer Corp~$50.7MSold out, 2.6% → 0.0% of the portfolio−1,717,500 shares
- Devon Energy Corp New~$41.8MSold out, 2.1% → 0.0% of the portfolio−1,009,800 shares
- Apache Corp~$38.1MSold out, 1.9% → 0.0% of the portfolio−903,000 shares
- Biogen Inc~$34.9MSold out, 1.8% → 0.0% of the portfolio−109,400 shares
- PayPal~$34.2MSold out, 1.7% → 0.0% of the portfolio−465,100 shares
Holdings
As of Mar 31, 2018; changes in shares since Dec 31, 2017.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| AlphabetCAP STK CL A · shares +0.7% · price −1.5% | 14.9% | $268.8M | −$4.2M | ||||||
| AmazonCOM · shares +1.7% · price +23.8% | 13.7% | $247.3M | +$46.7M | ||||||
| MicrosoftCOM · shares −25% · price +6.7% | 12.3% | $221.8M | +$13.9M | ||||||
| SalesforceCOM · shares −0.5% · price +13.8% | 11.0% | $198.3M | +$24.0M | ||||||
| IntelCOM · shares New | 7.1% | $128.3M | — | ||||||
| Nektar TherapeuticsCOM · shares −35% · price +77.9% | 7.0% | $126.7M | +$55.5M | ||||||
| AlibabaSPONSORED ADS · shares New | 6.7% | $120.7M | — | ||||||
| MicronCOM · shares New | 6.3% | $114.1M | — | ||||||
| WorkdayCL A · shares −32% · price +24.9% | 4.0% | $72.4M | +$14.4M | ||||||
| Jd Com IncSPON ADR CL A · shares +62% · price −2.2% | 4.0% | $72.2M | −$1.0M | ||||||
| NetflixCOM · shares New | 3.1% | $56.0M | — | ||||||
| Stamps Com IncCOM NEW · shares −6.0% · price +6.9% | 1.8% | $31.8M | +$2.1M | ||||||
| AdobeCOM · shares New | 1.5% | $26.5M | — | ||||||
| Tal Ed GroupSPONSORED ADS · shares New | 1.4% | $25.3M | — | ||||||
| Ac Immune SaSHS · shares 0% · price −19.2% | 1.4% | $24.7M | −$5.9M | ||||||
| QualcommCOM · shares New | 1.3% | $22.8M | — | ||||||
| Ctrip Com Intl LtdAMERICAN DEP SHS · shares −58% · price +5.7% | 0.79% | $14.3M | +$770,836 | ||||||
| Yandex N VSHS CLASS A · shares 0% · price +20.5% | 0.66% | $12.0M | +$2.0M | ||||||
| Vipshop Hldgs LtdSPONSORED ADR · shares New | 0.53% | $9.5M | — | ||||||
| Sterling Bancorp DelCOM · shares New | 0.50% | $9.1M | — | ||||||
| Intra Cellular Therapies IncCOM · shares New | 0.35% | $6.3M | — | ||||||
| Pagseguro Digital Ltd ComCL A · shares New | 0.07% | $1.3M | — | ||||||
| Total 22 positions | 100% | $1.81B | +$148.3M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2017 to Q1 2018: 11 stocks held throughout, up $148.3M (+13.4%).
- Nektar Therapeutics+$55.5M+78%
- Amazon+$46.7M+24%
- Salesforce+$24.0M+14%
- Workday+$14.4M+25%
- Microsoft+$13.9M+7%
- Jd Com Inc−$1.0M−2%
- Alphabet−$4.2M−2%
- Ac Immune Sa−$5.9M−19%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | $4.47B−14% | SEC ↗ |
| Q2 2026 | Aug 14, 2026 | $5.21B+54% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $3.38B−25% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $4.49B+11% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $4.06B−0% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $4.07B+33% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $3.06B−18% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $3.72B+26% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.95B+1% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.92B−34% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $4.39B+31% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $3.35B+20% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $2.79B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $2.87B+25% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $2.31B+14% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $2.02B+15% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $1.76B+28% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.38B−40% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.31B−16% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.76B−10% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $3.08B−24% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 (amended) | $4.04B−11% | SEC ↗ |
| Q1 2021 | May 17, 2021 (amended) | $4.53B+22% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.71B+8% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.44B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $3.27B+32% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.47B−28% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $3.41B+33% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.57B−24% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.37B−2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $3.45B+100% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $1.73B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $2.10B+2% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.07B+14% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.81B−9% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.98B−10% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.20B+18% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.87B+22% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.52B+49% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.03B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.13B+30% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $870.7M−35% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $1.34B | SEC ↗ |